[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@trialradar](/creator/twitter/trialradar)
"$JAZZ Phase III trial is important as it tests zanidatamab + chemo for metastatic HER2-positive breast cancer after or intolerance to T-DXd aiming to fill a major post-T-DXd treatment gap. @JazzPharma"  
[X Link](https://x.com/trialradar/status/1978851704842981624) [@trialradar](/creator/x/trialradar) 2025-10-16T15:53Z XXX followers, XX engagements


"Clinical Trial NCT07052253 tests Akesos AK104 + AK112 with TT-00420 (tinengotinib) in advanced Hepatocellular Carcinoma the most common liver cancer. 🧐 See this and all Akeso trials: 🔗"  
[X Link](https://x.com/trialradar/status/1955041403937214740) [@trialradar](/creator/x/trialradar) 2025-08-11T22:59Z XXX followers, XXX engagements


"The $OCGN GARDian3 study is a Phase II/III pivotal trial evaluating OCU410ST a gene therapy for Stargardt disease (STGD). This rare inherited eye disorder causes progressive vision loss from fatty deposits in the retina"  
[X Link](https://x.com/trialradar/status/1978239855969599772) [@trialradar](/creator/x/trialradar) 2025-10-14T23:21Z XXX followers, XXX engagements


"$BIVI Enrollment is open for the Phase X ADDRESS-LC trial testing NE3107 in adults with Long COVID. This anti-inflammatory crosses the blood-brain barrier and was previously studied in Alzheimers and Parkinsons. The study evaluates if NE3107 can improve persistent brain fog and fatigue. @BioVie_Pharma 🔗"  
[X Link](https://x.com/trialradar/status/1978891872178442562) [@trialradar](/creator/x/trialradar) 2025-10-16T18:32Z XXX followers, XXX engagements